News
ICViewExpert PerspectivesMedical World NewsVideosWebinars
Conference CoverageConference ListingAPIC Chapters
Infection Control TodaySupplements And Featured Publications
CME/CEEditorial Advisory BoardJob BoardPartnersSponsoredWhitepapers
Subscribe
Educator of the Year Official Rules2024 Educator of the Year Winner2023 Educator of the Year WinnerEducator of the Year
Advanced TechnologyAdvanced TechnologyAdvanced Technology
Bug of the Month
COVID-19
Environmental ServicesEnvironmental Services
HAIs
Hand Hygiene
IC Trends
Long-Term CareLong-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Policy
PreventionPreventionPreventionPrevention
Sterile ProcessingSterile Processing
Surface Disinfection
Vascular Access
Spotlight -
  • IC Trends
  • Bug of the Month
  • Featured Articles
  • Featured Columns
Advanced TechnologyAdvanced TechnologyAdvanced Technology
Bug of the Month
COVID-19
Environmental ServicesEnvironmental Services
HAIs
Hand Hygiene
IC Trends
Long-Term CareLong-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Policy
PreventionPreventionPreventionPrevention
Sterile ProcessingSterile Processing
Surface Disinfection
Vascular Access
    • News
    • Subscribe
Advertisement

Engineers Turn E. coli Into Tiny Factories for Producing New Forms of Popular Antibiotic

May 29, 2015
Article

Like a dairy farmer tending to a herd of cows to produce milk, researchers are tending to colonies of the bacteria Escherichia coli (E. coli) to produce new forms of antibiotics - including three that show promise in fighting drug-resistant bacteria. The research, which will be published May 29 in the journal Science Advances, was led by Blaine A. Pfeifer, an associate professor of chemical and biological engineering in the University at Buffalo School of Engineering and Applied Sciences. His team included first author Guojian Zhang, Yi Li and Lei Fang, all in the Department of Chemical and Biological Engineering.

White filter disks holding antibiotics sit on petri dishes housing erythromycin-resistant Bacillus subtilis. The filter disks circled in red hold new forms of erythromycin created by University at Buffalo researchers, and the dark halo around them indicates that the drug has seeped out of the disk to kill the surrounding bacteria. Image courtesy of Guojian Zhang

Like a dairy farmer tending to a herd of cows to produce milk, researchers are tending to colonies of the bacteria Escherichia coli (E. coli) to produce new forms of antibiotics - including three that show promise in fighting drug-resistant bacteria. The research, which will be published May 29 in the journal Science Advances, was led by Blaine A. Pfeifer, an associate professor of chemical and biological engineering in the University at Buffalo School of Engineering and Applied Sciences. His team included first author Guojian Zhang, Yi Li and Lei Fang, all in the Department of Chemical and Biological Engineering.

For more than a decade, Pfeifer has been studying how to engineer E. coli to generate new varieties of erythromycin, a popular antibiotic. In the new study, he and colleagues report that they have done this successfully, harnessing E. coli to synthesize dozens of new forms of the drug that have a slightly different structure from existing versions.

Three of these new varieties of erythromycin successfully killed bacteria of the species Bacillus subtilis that were resistant to the original form of erythromycin used clinically.

“We’re focused on trying to come up with new antibiotics that can overcome antibiotic resistance, and we see this as an important step forward,” says Pfeifer.

“We have not only created new analogs of erythromycin, but also developed a platform for using E. coli to produce the drug,” he says. “This opens the door for additional engineering possibilities in the future; it could lead to even more new forms of the drug.”

The study is especially important with antibiotic resistance on the rise. Erythromycin is used to treat a variety of illnesses, from pneumonia and whooping cough to skin and urinary tract infections.

Getting E. coli to produce new antibiotics has been something of a holy grail for researchers in the field.

That’s because E. coli grows rapidly, which speeds experimental steps and aids efforts to develop and scale up production of drugs. The species also accepts new genes relatively easily, making it a prime candidate for engineering.

While news reports often focus on the dangers of E. coli, most types of this bacteria are actually harmless, including those used by Pfeifer’s team in the lab.

Over the past 11 years, Pfeifer’s research has focused on manipulating E. coli so that the organism produces all of the materials necessary for creating erythromycin. You can think of this like stocking a factory with all the necessary parts and equipment for building a car or a plane.

With that phase of the research complete, Pfeifer has turned to the next goal: Tweaking the way his engineered E. coli produce erythromycin so that the drug they make is slightly different than versions used in hospitals today.

That’s the topic of the new Science Advances paper.

The process of creating erythromycin begins with three basic building blocks called metabolic precursors - chemical compounds that are combined and manipulated through an assembly line-like process to form the final product, erythromycin.

To build new varieties of erythromycin with a slightly different shape, scientists can theoretically target any part of this assembly line, using various techniques to affix parts with structures that deviate slightly from the originals. (On an assembly line for cars, this would be akin to screwing on a door handle with a slightly different shape.)

In the new study, Pfeifer’s team focused on a step in the building process that had previously received little attention from researchers, a step near the end.

The researchers focused on using enzymes to attach 16 different shapes of sugar molecules to a molecule called 6-deoxyerythronolide B. Every one of these sugar molecules was successfully adhered, leading, at the end of the assembly line, to more than 40 new analogs of erythromycin - three of which showed an ability to fight erythromycin-resistant bacteria in lab experiments.

“The system we’ve created is surprisingly flexible, and that’s one of the great things about it,” Pfeifer says. “We have established a platform for using E. coli to produce erythromycin, and now that we’ve got it, we can start altering it in new ways.”

Source: University at Buffalo 

Recent Videos
Anna Castillo-Gutierrez, CRCST, CSPDT, CHL, CIS, CFER,  and Maya Luera, CRCST, CIS, CER, CHL
Lucy Witt, MD
Chase Elms, BS, CRCST
Garrett Hollembeak, CRCST, CIS, CHL, CER, CIC
Hannah Schroeder, BSHA, CRCST, CIS, CHL, CER,
Anthony Bondon CRCST, CHL, BSM, AAS, SME, LSSYB
Deannard Esnard, CRCST, CIS, CER, CHL, CFER, CQUIA
Kevin Bush, Jr, DHSc, EdD, MSHA, MA, MS, FACHE
Vatsala Rangachar Srinivasa, MPH
Sarah Vinson, MBA, CRCST
Related Content

CDC: HICPAC Silenced  (Adobe Stock)

The Disbanding of HICPAC: A Dangerous Silencing in the Fight Against Health Care-Associated Infections

Heather Stoltzfus, MPH, RN, CIC
May 8th 2025
Article

The abrupt disbanding of HICPAC silences decades of infection control expertise, leaving health care workers without unified guidance as deadly threats to patient safety rise.


Endoscopy at the hospital. Doctor holding endoscope before gastroscopy  (Adobe Stock by romaset)

Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks

Alexander Sundermann, DrPH, CIC, FAPIC
May 7th 2025
Article

Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.


Policy: FY26 Discretionary Budget  (AI image created by author)

The Chopping Block: Administration’s FY26 Discretionary Budget Proposal Targets Public Health Lifelines

Brenna Doran, PhD, MA, ACC, CIC
May 5th 2025
Article

The proposed elimination of ASPR’s Hospital Preparedness Program in the 2026 federal budget could dismantle essential emergency readiness infrastructure and jeopardize national health care safety.


National Foundation for Infectious Diseases  (Image credit: NFID)

NFID 2025 Report Reveals Alarming Gaps in Hand Hygiene Practices Among US Adults

John Parkinson
May 5th 2025
Article

Clean Hospitals Corner With Alexandra Peters, PhD

Happy Hand Hygiene Day! Rethinking Glove Use for Safer, Cleaner, and More Ethical Health Care

Alexandra Peters, PhD
May 5th 2025
Article

Despite their protective role, gloves are often misused in health care settings—undermining hand hygiene, risking patient safety, and worsening environmental impact. Alexandra Peters, PhD, points out that this misuse deserves urgent attention, especially today, World Hand Hygiene Day.


IP LifeLine From Infection Control Today (AI image created by author)

IP LifeLine: Finding Your Footing: Deepening Resilience in the Daily Grind of Life

Brenna Doran, PhD, MA, ACC, CIC
May 1st 2025
Article

Infection preventionists face relentless demands, but true resilience begins when they replace self-judgment with grace, processing emotions with acceptance and compassion—not perfection.

Related Content

CDC: HICPAC Silenced  (Adobe Stock)

The Disbanding of HICPAC: A Dangerous Silencing in the Fight Against Health Care-Associated Infections

Heather Stoltzfus, MPH, RN, CIC
May 8th 2025
Article

The abrupt disbanding of HICPAC silences decades of infection control expertise, leaving health care workers without unified guidance as deadly threats to patient safety rise.


Endoscopy at the hospital. Doctor holding endoscope before gastroscopy  (Adobe Stock by romaset)

Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks

Alexander Sundermann, DrPH, CIC, FAPIC
May 7th 2025
Article

Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.


Policy: FY26 Discretionary Budget  (AI image created by author)

The Chopping Block: Administration’s FY26 Discretionary Budget Proposal Targets Public Health Lifelines

Brenna Doran, PhD, MA, ACC, CIC
May 5th 2025
Article

The proposed elimination of ASPR’s Hospital Preparedness Program in the 2026 federal budget could dismantle essential emergency readiness infrastructure and jeopardize national health care safety.


National Foundation for Infectious Diseases  (Image credit: NFID)

NFID 2025 Report Reveals Alarming Gaps in Hand Hygiene Practices Among US Adults

John Parkinson
May 5th 2025
Article

Clean Hospitals Corner With Alexandra Peters, PhD

Happy Hand Hygiene Day! Rethinking Glove Use for Safer, Cleaner, and More Ethical Health Care

Alexandra Peters, PhD
May 5th 2025
Article

Despite their protective role, gloves are often misused in health care settings—undermining hand hygiene, risking patient safety, and worsening environmental impact. Alexandra Peters, PhD, points out that this misuse deserves urgent attention, especially today, World Hand Hygiene Day.


IP LifeLine From Infection Control Today (AI image created by author)

IP LifeLine: Finding Your Footing: Deepening Resilience in the Daily Grind of Life

Brenna Doran, PhD, MA, ACC, CIC
May 1st 2025
Article

Infection preventionists face relentless demands, but true resilience begins when they replace self-judgment with grace, processing emotions with acceptance and compassion—not perfection.

Advertise
About Us
Editorial Board
Contact Us
Job Board
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News